Form 8-K - Current report:
SEC Accession No. 0001599298-25-000044
Filing Date
2025-02-24
Accepted
2025-02-24 06:08:58
Documents
40
Period of Report
2025-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K smmt-20250224.htm   iXBRL 8-K 33746
2 EX-99.1 pressreleaseq4december20.htm EX-99.1 31687
3 EX-99.2 q4andye2024earningsdeck_.htm EX-99.2 19374
7 pressreleaseq4december20001.jpg GRAPHIC 241803
8 pressreleaseq4december20002.jpg GRAPHIC 219984
9 pressreleaseq4december20003.jpg GRAPHIC 94792
10 pressreleaseq4december20004.jpg GRAPHIC 304678
11 pressreleaseq4december20005.jpg GRAPHIC 257236
12 pressreleaseq4december20006.jpg GRAPHIC 183355
13 pressreleaseq4december20007.jpg GRAPHIC 91709
14 pressreleaseq4december20008.jpg GRAPHIC 85683
15 pressreleaseq4december20009.jpg GRAPHIC 145680
16 pressreleaseq4december20010.jpg GRAPHIC 220698
17 pressreleaseq4december20011.jpg GRAPHIC 241882
18 pressreleaseq4december20012.jpg GRAPHIC 44422
19 q4andye2024earningsdeck_001.jpg GRAPHIC 58148
20 q4andye2024earningsdeck_002.jpg GRAPHIC 287141
21 q4andye2024earningsdeck_003.jpg GRAPHIC 135004
22 q4andye2024earningsdeck_004.jpg GRAPHIC 156158
23 q4andye2024earningsdeck_005.jpg GRAPHIC 117656
24 q4andye2024earningsdeck_006.jpg GRAPHIC 152582
25 q4andye2024earningsdeck_007.jpg GRAPHIC 130310
26 q4andye2024earningsdeck_008.jpg GRAPHIC 127907
27 q4andye2024earningsdeck_009.jpg GRAPHIC 106017
28 q4andye2024earningsdeck_010.jpg GRAPHIC 98690
29 q4andye2024earningsdeck_011.jpg GRAPHIC 121326
30 q4andye2024earningsdeck_012.jpg GRAPHIC 109568
31 q4andye2024earningsdeck_013.jpg GRAPHIC 58211
  Complete submission text file 0001599298-25-000044.txt   5451503

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20250224.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20250224_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20250224_pre.xml EX-101.PRE 12512
42 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20250224_htm.xml XML 2735
Mailing Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131
Business Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131 305-203-2034
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 371979717 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 25654063
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)